Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 9

Review

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

       
Total article views   HTML views PDF downloads Totals
13,482 Dovepress* 12,240+ 2,416 14,656
PubMed Central* 1,242 632 1,874
Totals 13,482 3,048 16,530
*Since 15 March 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar